Skip to search formSkip to main contentSkip to account menu

Hyperlipidemia, Familial Combined

Known as: FCHL, Hyperlipidemias, Familial Combined, Multiple Lipoprotein-Type Hyperlipidemias 
A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes… 
National Institutes of Health

Related topics

Related topics

18 relations
Eyelid XanthomaHyperlipoproteinemia Type IIIHyperlipoproteinemia Type IIbHyperlipoproteinemia Type V

Narrower (2)

HYPERLIPIDEMIA, COMBINED, 1Hyperlipidemia, Combined, 2

Broader (1)

Hyperlipidemia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screening.
2008
2008
A PCSK9 variant and familial combined hyperlipidaemia
Background: Our discovery in 2003 of the first mutations of PCSK9 gene causing autosomal dominant hypercholesterolaemia (ADH… 
Highly Cited
2003
Highly Cited
2003
Contribution of visceral adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance.
OBJECTIVE Impaired glucose tolerance (IGT) has been associated with alterations in numerous coronary heart disease risk factors… 
Highly Cited
2002
Highly Cited
2002
Increased Intima-Media Thickness in Familial Combined Hyperlipidemia Associated With Apolipoprotein B
The aim of the present study was to quantify intima-media thickness (IMT) in familial combined hyperlipidemia (FCHL) and to… 
2000
2000
Lipoprotein analysis using agarose gel electrophoresis and differential staining of lipids.
Highly Cited
1998
Highly Cited
1998
Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study
OBJECTIVE To compare the lipid-lowering efficacies of simvastatin and gemfibrozil in NIDDM patients with combined (mixed… 
1996
1996
Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
Tissue factor pathway inhibitor (TFPI), a kunitztype inhibitor of the extrinsic coagulation pathway, factor VII coagulant (FVIIc… 
Highly Cited
1994
Highly Cited
1994
Familial idiopathic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor.
Familial hypofibrinolysis with 3 generation, autosomal dominant, very high levels of plasminogen activator inhibitor activity… 
Highly Cited
1988
Highly Cited
1988
Combination drug therapy for familial combined hyperlipidemia.
STUDY OBJECTIVE To compare the efficacy of gemfibrozil and colestipol with gemfibrozil and lovastatin in patients with familial… 
Highly Cited
1983
Highly Cited
1983
Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia.
Hyperapobetalipoproteinemia is defined as the combination of a normal low density lipoprotein (LDL) cholesterol in the face of an… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)